Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Radient Pharmaceuticals Corp. (RPC) Appoints Seasoned Director to Head North American Sales

Radient Pharmaceuticals Corp. focuses on developing and commercializing diagnostic tests that assist physicians in answering important clinical questions related to early disease detection, including its Onko-Sure® In Vitro Diagnostic (IVD) cancer test.

The company today announced it has appointed Gary Giarrantano as director of North American Sales for the company where he will be responsible for managing the company’s sales and marketing strategy, operations and Onko-Sure(R) IVD product sales.

Giarratano has more than 20 years of healthcare, sales and marketing leadership experience. He is recognized for his contributions in new market development for Carcinoembryonic Antigen (CEA), Prostate-Specific Antigen (PSA) and Human Papillomavirus (HPV), and led sales for the first company to secure U.S. FDA approval on each of these assays.

Giarratano’s sales experience includes positions with established and emerging healthcare and pharmaceutical companies, including Qiagen, Roche Diagnostics, AutoGenomics Inc., Sebia Inc., Esoterix Laboratory, PerkinElmer Life Sciences and Hybritech Inc.

Radient said that Giarratano’s proven track record in the industry makes the company confidant he can increase the market reach of Onko-Sure.

“Gary thoroughly understands the intricacies of the IVD marketplace and has repeatedly successfully driven market share for various new test kit products. We expect him to do the same for Onko-Sure,” Douglas MacLellan, chairman and CEO of Radient stated in the press release. “Giarratano has demonstrated talent in strategically aligning sales objectives with marketplace demands, and meeting those demands through proven sales performance. His wealth of expertise in the IVD industry combined with a proven ability to deliver results makes him an exceptional leader we believe will help propel sales of Onko-Sure to the next level.”

Giarratano has established key professional relationships with major healthcare companies such as Quest, Lab Corp., Mayo, Kaiser, MetroPath, UniPath, Summit Pathology, TriCore, Intermountain Health Care and other regional reference labs.

For more information visit

Let us hear your thoughts below:

This entry was posted in Small Cap News. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *